Glenmark Pharmaceuticals received the final approval for Colesevelam Hydrochloride oral suspension from the US drug regulator. Also, the company has completed the formalities for the acquisition of Pune-based firm, Zorg Labs.

The new product will be available across Retail and Modern Trade outlets in India and will be sponsored through a 360-degree campaign that will commence shortly.

The stocks of freight vehicle manufacturers were pounded severely during the last trading session, but on Tuesday, the stocks were back in the green as the market delved into the details of the new guidelines.

The Indian Rupee has been on a losing streak against the dollar, which is a point of worry for the domestic investors. Many investors are looking for potential opportunities and ways to reap returns in this environment.

Overall volumes in futures & options currently stand at 64.98 lakh contracts with a turnover of Rs. 5,79,798.56 crore.

Overall volumes in futures & options currently stand at 64.98 lakh contracts with a turnover of Rs. 5,79,798.56 crore.

Monday’s session low (10,926) would be a crucial level for the coming session as this level is near about the May high of 10,929. However, a fall below this level would lead to a further decline up to the level of 10,879, which is 38.2 per cent retracement of the recent upmove, followed by 10,833 level, which is an important short-term moving average, i.e. 20-day EMA. Stocks in news: Adani Ports, BEML, Dilip Buildcon and BEL. 

Indian equities are expected to open lower amid negative global cues. The Nifty 50 index future on the Singapore stock exchange is currently trading down by 10 points at 10,936.

India INX changes name of ‘S&P BSE SENSEX 50 Futures & Options contracts’ to ‘India 50 Futures & Options contracts’ 

Lupin shares fell by 3  per cent  intraday despite the announcement of successful completion of inspection of its Goa facility by the UK MHRA.